Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Etilevodopa is an ethyl-ester prodrug of Levodopa which is used for the treatment of Parkinson's disease (PD). It is rapidly hydrolyzed to Levodopa and ethanol by nonspecific esterases in the gastrointestinal tract. Levodopa is the direct precursor of dopamine.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Etilevodopa is an ethyl-ester prodrug of Levodopa which is used for the treatment of Parkinson's disease (PD). It is rapidly hydrolyzed to Levodopa and ethanol by nonspecific esterases in the gastrointestinal tract. Levodopa is the direct precursor of dopamine. |
In vitro | Etilevodopa passes unchanged through the stomach to the duodenum and is subsequently absorbed into the bloodstream as Levodopa [1]. Etilevodopa has a greater solubility in the stomach, faster passage to the small intestine, and a shortened time to maximum Levodopa concentration, compared with standard Levodopa [2]. |
Synonyms | Levodopa ethyl ester, L-DOPA ethyl ester |
Molecular Weight | 225.24 |
Formula | C11H15NO4 |
CAS No. | 37178-37-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Etilevodopa 37178-37-3 Others Levodopa ethyl ester L-DOPA ethyl ester inhibitor inhibit